Pertuzumab: new hope for patients with HER2-positive breast cancer. (Record no. 22041525)

MARC details
000 -LEADER
fixed length control field 01377 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516105752.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201307s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1569-8041
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1093/annonc/mds328
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Capelan, M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20130702
245 00 - TITLE STATEMENT
Title Pertuzumab: new hope for patients with HER2-positive breast cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Annals of oncology : official journal of the European Society for Medical Oncology
Date of publication, distribution, etc. Feb 2013
300 ## - PHYSICAL DESCRIPTION
Extent 273-282 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dimerization
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptor, ErbB-2
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Trastuzumab
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pugliano, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name De Azambuja, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bozovic, I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Saini, K S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sotiriou, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Loi, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Piccart-Gebhart, M J
773 0# - HOST ITEM ENTRY
Title Annals of oncology : official journal of the European Society for Medical Oncology
Related parts vol. 24
-- no. 2
-- p. 273-282
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1093/annonc/mds328">https://doi.org/10.1093/annonc/mds328</a>
Public note Available from publisher's website

No items available.